Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Orit Rosenberg

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Heliyon|January 24, 2020
Safety and efficacy of <i>in vitro</i> generated bone-like material for in vivo bone regeneration - a feasibility studyNahum Rosenberg, Orit Rosenberg
Rambam Maimonides Medical Journal|August 3, 2013
Osteoblasts in bone physiology-mini reviewNahum Rosenberg, Orit Rosenberg, Michael Soudry
Progress in Cardiovascular Nursing|March 8, 2003
Cardiovascular nursing in IsraelYosef Blaer, Orit Rosenberg, Leonardo Reisin
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|September 28, 2017
In vitro Effects of the Specific Mitochondrial TSPO Ligand Ro5 4864 in Cultured Human OsteoblastsNahum Rosenberg, Orit Rosenberg, Abraham Weizman, et al.
Journal of Bioenergetics and Biomembranes|February 18, 2014
In vitro effect of FGIN-1-27, a ligand to 18 kDa mitochondrial translocator protein, in human osteoblast-like cellsNahum Rosenberg, Orit Rosenberg, Abraham Weizman, et al.
Journal of Bioenergetics and Biomembranes|March 12, 2013
In vitro catabolic effect of protoporphyrin IX in human osteoblast-like cells: possible role of the 18 kDa mitochondrial translocator proteinNahum Rosenberg, Orit Rosenberg, Abraham Weizman, et al.
Cytotechnology|November 13, 2008
Measurement of [(18)F]-fluorodeoxyglucose incorporation into human osteoblast-An experimental methodNahum Rosenberg, Lise Bettman, Orit Rosenberg, et al.
Diabetes Care|July 17, 2025
Gradual Titration of Semaglutide Results in Better Treatment Adherence and Fewer Adverse Events: A Randomized Controlled Open-Label Pilot Study Examining a 16-Week Flexible Titration Regimen Versus Label-Recommended 8-Week Semaglutide Titration RegimenRoy Eldor, Noa Avraham, Orit Rosenberg, et al.
Diabetes Care|December 3, 2025
Erratum. Gradual Titration of Semaglutide Results in Better Treatment Adherence and Fewer Adverse Events: A Randomized Controlled Open-Label Pilot Study Examining a 16-Week Flexible Titration Regimen Versus Label-Recommended 8-Week Semaglutide Titration Regimen Diabetes Care 2025;48:1607-1611Roy Eldor, Noa Avraham, Orit Rosenberg, et al.
Journal of Bioenergetics and Biomembranes|December 1, 2011
In vitro mitochondrial effects of PK 11195, a synthetic translocator protein 18 kDa (TSPO) ligand, in human osteoblast-like cellsNahum Rosenberg, Orit Rosenberg, Abraham Weizman, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Heliyon|January 24, 2020
Safety and efficacy of <i>in vitro</i> generated bone-like material for in vivo bone regeneration - a feasibility studyNahum Rosenberg, Orit Rosenberg
Rambam Maimonides Medical Journal|August 3, 2013
Osteoblasts in bone physiology-mini reviewNahum Rosenberg, Orit Rosenberg, Michael Soudry
Progress in Cardiovascular Nursing|March 8, 2003
Cardiovascular nursing in IsraelYosef Blaer, Orit Rosenberg, Leonardo Reisin
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|September 28, 2017
In vitro Effects of the Specific Mitochondrial TSPO Ligand Ro5 4864 in Cultured Human OsteoblastsNahum Rosenberg, Orit Rosenberg, Abraham Weizman, et al.
Journal of Bioenergetics and Biomembranes|February 18, 2014
In vitro effect of FGIN-1-27, a ligand to 18 kDa mitochondrial translocator protein, in human osteoblast-like cellsNahum Rosenberg, Orit Rosenberg, Abraham Weizman, et al.
Journal of Bioenergetics and Biomembranes|March 12, 2013
In vitro catabolic effect of protoporphyrin IX in human osteoblast-like cells: possible role of the 18 kDa mitochondrial translocator proteinNahum Rosenberg, Orit Rosenberg, Abraham Weizman, et al.
Cytotechnology|November 13, 2008
Measurement of [(18)F]-fluorodeoxyglucose incorporation into human osteoblast-An experimental methodNahum Rosenberg, Lise Bettman, Orit Rosenberg, et al.
Diabetes Care|July 17, 2025
Gradual Titration of Semaglutide Results in Better Treatment Adherence and Fewer Adverse Events: A Randomized Controlled Open-Label Pilot Study Examining a 16-Week Flexible Titration Regimen Versus Label-Recommended 8-Week Semaglutide Titration RegimenRoy Eldor, Noa Avraham, Orit Rosenberg, et al.
Diabetes Care|December 3, 2025
Erratum. Gradual Titration of Semaglutide Results in Better Treatment Adherence and Fewer Adverse Events: A Randomized Controlled Open-Label Pilot Study Examining a 16-Week Flexible Titration Regimen Versus Label-Recommended 8-Week Semaglutide Titration Regimen Diabetes Care 2025;48:1607-1611Roy Eldor, Noa Avraham, Orit Rosenberg, et al.
Journal of Bioenergetics and Biomembranes|December 1, 2011
In vitro mitochondrial effects of PK 11195, a synthetic translocator protein 18 kDa (TSPO) ligand, in human osteoblast-like cellsNahum Rosenberg, Orit Rosenberg, Abraham Weizman, et al.
Pageof 1